Wang Qingxia, Cao Xiaoxia, Wu Xiuying, Liu Jiangfeng, Xie Jingwen, Hou Deren
Department of Digestive Endoscopy, Xiangya Hospital, Central South University, Changsha 410008, China.
Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Sep 30;40(9):1369-1372. doi: 10.12122/j.issn.1673-4254.2020.09.23.
To investigate the status of anxiety and depression in patients requiring emergency treatment during the epidemic of COVID-19 to identify the patients with acute psychological stress disorder.
During the COVID-19 epidemic, the medical staff divided the patients visiting the emergency department into suspected group, fever group and control group through interview of the patients at triage. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were distributed to each patient, and a trained medical staff was responsible for assisting the patient to complete the scales.
A total of 557 sets of scales were distributed, including 211 in suspected COVID-19 case group, 167 in fever group and 179 in the control group. A total of 516 scales were retrieved, including 197 in suspected case group, 151 in fever group and 168 in control group. In the 3 groups, the incidence rates of anxiety and depression were 57.87% and 58.88%, 48.34% and 43.71%, and 18.31% and 18.99%, respectively, and the rates were significantly higher in suspected group and fever group than in the control group ( < 0.01), and significantly higher in suspected group than in fever group ( < 0.05). The standardized anxiety and depression scale scores in suspected case group, fever group and control group were 57.38±16.25 and 42.58±14.27, 51.23±15.29 and 38.32±15.39, and 32.58±17.8 and 12.25±12.94, respectively. Compared with the control group, both suspected case group and fever group had significantly higher standard scores for anxiety and depression ( < 0.01), and suspected case group had significantly higher standardized scores than fever group ( < 0.01).
Among the patients visiting the emergency treatment, the patients with suspected COVID-19 and common fever are more likely to develop anxiety and depressive symptoms.
调查新型冠状病毒肺炎（COVID-19）疫情期间急诊患者的焦虑和抑郁状况，以识别急性心理应激障碍患者。
在COVID-19疫情期间，医护人员在分诊时通过询问患者将前来急诊科就诊的患者分为疑似组、发热组和对照组。向每位患者发放焦虑自评量表（SAS）和抑郁自评量表（SDS），由经过培训的医护人员协助患者完成量表填写。
共发放量表557份，其中COVID-19疑似病例组211份，发热组167份，对照组179份。共回收量表516份，其中疑似病例组197份，发热组151份，对照组168份。3组中焦虑和抑郁的发生率分别为57.87%和58.88%、48.34%和43.71%、18.31%和18.99%，疑似组和发热组的发生率显著高于对照组（P<0.01），且疑似组显著高于发热组（P<0.05）。疑似病例组、发热组和对照组的焦虑和抑郁量表标准化得分分别为57.38±16.25和42.58±14.27、51.23±15.29和38.32±15.39、32.58±17.8和12.25±12.94。与对照组相比，疑似病例组和发热组的焦虑和抑郁标准得分均显著更高（P<0.01），且疑似病例组的标准化得分显著高于发热组（P<0.01）。
在急诊就诊患者中，COVID-19疑似患者和普通发热患者更易出现焦虑和抑郁症状。
